ADVENTRX Completes Acquisition of SynthRx
ADVENTRX and SynthRx, a private biotechnology company, completed a definitive merger on April 8, 2011.
OneMedForum Sf 2011
New Software From iCAD Helps Doctors Diagnose Prostate Cancer
New software being used at Englewood Hospital and Medical Center should help detect prostate cancer earlier, eliminate unnecessary testing procedures and help form a treatment plan.
Global In Vitro Diagnostic Market Analysis
A new market research report on the In Vitro Diagnostic market is now available in the reportlinker.com catalogue.
The Neurology Market: A Glance (video)
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying causes of these diseases are far from certain.
EpiCept Corporation Announces Year End Results and Updates On Clinical Trials Surrounding Cancer Treatment
EpiCept Corporation recently announced operating and financial results for the year 2010, and provided an update on its key business initiatives.
ECI Biotech Can Sense Infection
An innovative approach to wound care, ECI Biotech makes simple and affordable sensors, branded, ExpressDetect, that turn blue in the presence of harmful microbial pathogens.
OneMedForum SF 2011 Orthopedics Panel Review (Video)
A panel of experts in the field sat down at OneMedForum SF 2011 to discuss the large number of very innovative solutions in development which should offer the large orthopedic companies an opportunity to grow rapidly during the coming years.
A Forecast in The Diagnostic Market (video)
Advances in molecular biology now make it possible to detect diseases sooner, allowing physicians to advise patients on optimal therapies. “Global Molecular Diagnostics Market: Opportunities & Future Forecast” reports that based on its exceptional ability to accurately detect the primary cause of disease, molecular diagnostics has emerged as the fastest growing segment of the in vitro diagnostics (IVD) industry.
QR Pharma Develops Drugs To Treat Alzheimer’s Disease
Alzheimer’s disease affects more than 26 million people worldwide. This number is expected to grow to more than 106 million in 2050. Its economic burden and impact on patient wellness and quality of life for both patients and their caregivers is crushing.
Hunting Disease In The Dark: MEDomics Seeks to Treat Mitochondrial Disease Before It Occurs
The core theory behind preventative medicine is almost psychic. To stop a disease from wielding its mighty weapons before it occurs is based on foreknowledge of a patient’s susceptibility to the illness.